March 1, 2014
Post 30 – Road to a Million,
Well the last post started out with the New England Journal of Medicine was to report results of the ACT trials. Well not sure what the hold up is but so far its not been posted. Till this initial results get posted and published, ACTC stock value will sit pretty much where it is.
So what is going on? Why the silence, why so quiet? A number of presentations have happened, and not much
January 26, 2014
Post 29 – Road to a Million,
OMG everyone, It has been announced that the New England Journal of Medicine will report the results of the ACT Clinical Trials for AMD and Stargardts!! There was a conference in Rome Saturday and the announcement was made there. Generally these announcements are allowed just before the results are published. The next printing of the Journal is Wednesday January 29th!!
This is the link to the conference that happened
The first time I believed ACT was on the brink of worldwide acclaim lured ahead of the first approval and subsequent injections. The second time I rejoiced prior to the Lancet, which continued on throughout the 2012 ASM time period.
My visceral objections were subsided by thoughts of clinical celerity. Looking back, ACT was nothing more than a babushka doll fashioned as a paragon of the biotech industry.
Here I was, still anticipating hysteria at any moment. With
Updated 01-21-2014 at 11:53 PM by Wallace907
The Japanese proposed trial on RPEs ARE NOT THE TRIALS OR EVEN CLOSE TO BEING EQUIVALENT TO WHAT LANZA/ACTC ARE DOING!
IT IS IN FACT A "PRE-CLINICAL" USING HUMANS. AND NO FOUNDATION OF SAFETY PROFILE TO BEGIN WITH!
The process being used by Rikken is an "Exemption Process" that goes around Japan's Established Trial Standards.THIS WOULD NEVER HAVE HAPPENED IN THE US.
IT IS AN EXPERIMENT!
I personally, do not have any issues with it. What
I finally finished a thorough analysis and research on one of my investment which is MGT. I promised you guys this document so wanted to share it with you! Both ACTC Stem Cell Company and this MGT are the main stocks I'm currently in and feel confident. Again I'm not an expert and could lose all your money if you follow any of my investments.
One of my lessons learn from last year was to put more effort in understanding my investment inside and this is one of my first attempt. By
Copyright © 2013 InvestorStemcell.com - All Rights ReservedContent Relevant URLs by vBSEO 3.6.0 PL2
Website design by: Relivo Media